FDA approves new pancreatic cancer drug that could extend patients' lives

CBS News
Published
Read the full story at CBS NewsOriginal

Patients taking the first-of-a-kind pill, called daraxonrasib, lived for a median of 13.2 months compared with 6.7 months for chemotherapy recipients, studies showed.

Have a take on this story? Discuss it on Gab — no account needed to read, free to join to post.

Discuss on Gab

Want a second read? Ask Gab AI to analyze this story — private, no account needed to start.

Ask Gab AI
Reading the article

💡 AI analysis provides alternative perspectives on current events

Support Alto & Gab

Alto is funded entirely by readers like you. Your donation helps us continue delivering curated news from a right-wing Christian Nationalist perspective, powered by Gab AI.

Gab Shop

Support free speech with official merchandise

Gab Emblem America 250 T-Shirt
Shop Now

Gab Emblem America 250 T-Shirt

America 250 Liberty Bell T-Shirt
Shop Now

America 250 Liberty Bell T-Shirt

Go Home America for Americans T-Shirt
Shop Now

Go Home America for Americans T-Shirt

Deport Them All Garden Flag
Shop Now

Deport Them All Garden Flag

View All Products

Install Alto on Your Phone

Add Alto to your home screen for quick access to breaking news — no app store required.

iPhone & iPad

Using Safari Browser

1

Open alto.gab.com in Safari

alto.gab.com
2

Tap the Share button

at the bottom of Safari
3

Tap "More"

More
4

Scroll and tap "Add to Home Screen"

Add to Home Screen

Tap "Add" to confirm

Alto will appear on your home screen like any other app!

Android

Using Chrome Browser

1

Open alto.gab.com in Chrome

alto.gab.com
2

Tap the menu button

three dots in top right
3

Tap "Add to Home screen"

Add to Home screen

Tap "Add" to confirm

Alto will appear on your home screen like any other app!
gab

Follow the World Unfiltered

Read what people in the story are actually saying, not what a foreign censorship request left behind.

g
Login to GabSign Up

What Makes Gab Different

We're not just another social network. We're a platform built on principles that matter.

Freedom of Speech & Reach

All First Amendment protected speech is welcome. No algorithmic throttling or shadow banning.

Family-Friendly Platform

We maintain a clean environment. Explicit adult content is strictly prohibited.

Western Nations Only

Third-world IPs are blocked. No scammers, no spam farms. Built for Western civilization.

Funded By Users

Our users are our investors and customers. You're not the product being sold.

Battle Tested

A decade of standing strong. Banned from app stores, banks—and still here.

American Owned & Operated

We reject foreign censorship demands. Built by Americans, for free people.